Circulating Tumor Cells in Early and Advanced Breast Cancer; Biology and Prognostic Value.

Int J Mol Sci · 2020 · PMC7084781 · PMID 32121386

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The median PFS was 10.5 months with HT in the clinically- driven arm for those with a high CTC count versus 15.5 months with CT in the CTC-driven arm and showed a trend toward longer OS (median, 37.1 vs. 42.0 months, respectively).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.